Patent · US Active

Targeting ABCB5 for cancer therapy

US9266946B2 · kind B2 · utility

9Cited by

32References

13Claims

0Family size

Assignee

The Brigham and Women's Hospital, Inc. · US

Inventors

Markus Frank · Baden-Baden, DE
Natasha Y. Frank · Cambridge, US
Mohamed H. Sayegh · Dedham, US

Key dates

Filing date	Apr 14, 2014
Grant date	Feb 23, 2016
Priority date	—
Expiry date	Apr 14, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/705
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to methods for treating a subject by manipulating ABCB5 on a cell as well as related products. The methods include methods of treating cancer using ABCB5 binding molecules such as antibodies and fragments thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.